Stericycle, Inc. (NASDAQ:SRCL) is scheduled to present at the 2010 Jefferies Global Healthcare Services Conference on Wednesday, January 27. Speaking on behalf of the company will be Executive Vice President, International, Rich Foss. Mr. Foss will begin his presentation at 1:15 pm ET that afternoon. For more information regarding the company’s participation at the conference, contact Frank ten Brink of Stericycle at 847.607.2012.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Stericycle, Inc. is engaged in the management of regulated waste and providing an array of related services. The Company operates in the United States, Canada, Mexico, Argentina, Chile, the United Kingdom and Ireland. Its national networks include a total of 89 processing or combined processing and collection sites, and 97 additional transfer, collection or combined transfer and collection sites. Stericycle, Inc.’s regulated waste processing technologies include autoclaving, its own electro-thermal-deactivation system (ETD), chemical treatment and incineration. During the year ended December 31, 2008, the Company completed 22 acquisitions, of which 12 were domestic regulated waste businesses, two were domestic return management businesses and eight were international regulated waste businesses in Canada, Latin America and Europe. In December 2009, the Company completed its acquisition of MedServe, Inc.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
